Clozapine and speech dysfluency: Two case reports

Psychiatric Bulletin

Volumn 31, Issue 1, 2007, Pages 16-18

  Lyall, Marc ^a   Pryor, Angela ^a   Murray, Kevin ^a  

^a BROADMOOR HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; FLUPENTIXOL DECANOATE; HALOPERIDOL DECANOATE; OLANZAPINE; QUETIAPINE; RISPERIDONE; TETRABENAZINE; VALPROIC ACID; ZUCLOPENTHIXOL DECANOATE;

ADJUVANT THERAPY; ADULT; ARTICLE; BODY MOVEMENT; CLINICAL ARTICLE; CONVALESCENCE; DELUSIONAL DISORDER; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSARTHRIA; DYSTONIA; ELECTROENCEPHALOGRAM; FLUENCY DISORDER; HICCUP; HIGH RISK PATIENT; HUMAN; HYPERKINESIA; LIMB MOVEMENT; MALE; MENTAL DETERIORATION; MUSCLE CONTRACTION; OROFACIAL DYSKINESIA; PARANOID SCHIZOPHRENIA; PATIENT COMPLIANCE; PHONATION; PSYCHOSIS; SEIZURE THRESHOLD; SIDE EFFECT; SPEECH DISORDER; SPEECH RATE; STUTTERING; TIC; VOICE;

EID: 33846252819     PISSN: 09556036     EISSN: None     Source Type: Journal    
DOI: 10.1192/pb.31.1.16     Document Type: Article

References (17)

1. ADLER, L., LEONG, S. & DELGATO, R. (1987) Drug-induced stuttering treated with propanolol. Journal of Clinical Psychopharmacology, 7, 115-116.
2. AMERICAN PSYCHIATRIC ASSOCIATION (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA.
3. ANDREWS, G., NEILSON, M. & CURLEE, R. (1988) Stuttering. JAMA, 260, 1445.
4. COLLABORATIVE WORKING GROUP ON CLINICAL TRIAL EVALUATIONS (1998) Adverse effects of the atypical antipsychotics. Journal of Clinical Psychiatry, 59 (suppl. 12), 17-22.
5. CRAIG, A., HANCOCK, K., TRAN, Y., et al (2002) Epidemiology of stuttering in the communication across the entire life span. Journal of Speech Language and Hearing Research, 45, 1097-1105.
6. DUGGAL, H. S., JAGADHEESAN, K. & NIZAMIE, S. H. (2002) Clozapine-induced stuttering and seizures. American Journal of Psychiatry, 159, 315.
7. EBELING, T. A., COMPTON, A. D. & ALBRIGHT, D.W. (1997) Clozapine-induced stuttering. American Journal of Psychiatry, 154, 1473.
8. GUITAR, B. E. (1985) Stuttering and stammering. Pediatric Reviews, 7, 163-168.
9. KOUKKOU, M., ANGST, J. & ZIMMER, D. (1979) Paroxysmal EEG activity and psychopathology during the treatment with clozapine. Psychopharmacology 12, 173-183.
10. MENKES, D. B. & UNGARVI, G. S. (1993) Adult-onset stuttering as a presenting feature of schizophrenia: restoration of fluency with trifluoperazine. Journal of Nervous and Mental Disease, 181, 64-65.
11. MURDOCH, B. E. (1990) Acquired Speech and Language Disorders: A Neuroanatomical and Functional Neurological Approach. Chapman & Hall.
12. NURNBERG, H. G. & GREENWALD, B. (1981) Stuttering: an unusual side effect of phenothiazines. American Journal of Psychiatry, 138, 386-387.
13. ROGERS, D. (1985) The motor disorders of severe psychiatric illness: a conflict of paradigms. British Journal of Psychiatry, 147, 221-232.
14. SUPPRIAN, T., RETZ, W. & DECKERT, J. (1994) Clozapine-induced stuttering: epileptic brain activity. American Journal of Psychiatry, 156, 1663.
15. TAYLOR, D., PATON, C. & KERWIN, R. (2005) The South London and Maudsley NHS Trust Oxleas NHS Trust 2005-2006 Prescribing Guidelines, (8th edn). Taylor & Francis.
16. THOMAS, P., LALAUX, N., VAIVA, G., et al (1994) Dose-dependent stuttering and dystonia in a patient taking clozapine. American Journal of Psychiatry, 151, 1096.
17. WEISS, S. R. B., POST, R. M., SZELE, F., et al (1989) Chronic carbamazepine inhibits the development of local anaesthetic seizures kindled by cocaine and lidocaine. Brain Research, 497, 72-79.